SIMILAR PATTERNS OF AMINO ACIDS FOR 6DJ1_B_AB1B201_0

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1awb MYO-INOSITOL
MONOPHOSPHATASE


(Homo sapiens)
PF00459
(Inositol_P)
5 GLY A 207
ALA A 208
ASP A 209
GLY A 189
VAL A 193
None
None
None
CL  A 280 ( 4.1A)
None
0.65A 6dj1A-1awbA:
undetectable
6dj1A-1awbA:
17.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b7g PROTEIN
(GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE)


(Sulfolobus
solfataricus)
PF01113
(DapB_N)
PF02800
(Gp_dh_C)
5 ALA O  43
GLY O  13
GLY O  10
VAL O  52
ILE O  50
None
None
SO4  O 610 ( 3.8A)
None
None
0.80A 6dj1A-1b7gO:
undetectable
6dj1A-1b7gO:
12.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d4e FLAVOCYTOCHROME C
FUMARATE REDUCTASE


(Shewanella
oneidensis)
PF00890
(FAD_binding_2)
PF14537
(Cytochrom_c3_2)
5 ALA A 167
GLY A 162
GLY A 161
VAL A 554
ILE A 550
FAD  A 600 (-3.7A)
FAD  A 600 (-3.2A)
None
None
FAD  A 600 (-4.3A)
0.79A 6dj1A-1d4eA:
undetectable
6dj1A-1d4eA:
10.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.43A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.48A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.93A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.72A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-4.1A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.57A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
GLY A  49
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.7A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.54A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  48
GLY A  49
ILE A  50
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.56A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  48
GLY A  49
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.7A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.64A 6dj1A-1hvcA:
14.0
6dj1A-1hvcA:
41.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jr6 HELICASE NS3

(Hepacivirus C)
PF00271
(Helicase_C)
5 GLY A  36
ASP A  95
GLY A 123
GLY A 128
ILE A 129
None
0.77A 6dj1A-1jr6A:
undetectable
6dj1A-1jr6A:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q3x MANNAN-BINDING
LECTIN SERINE
PROTEASE 2


(Homo sapiens)
PF00084
(Sushi)
PF00089
(Trypsin)
5 GLY A 667
GLY A 650
GLY A 651
VAL A 588
ILE A 590
GOL  A 701 ( 4.0A)
None
None
None
None
0.87A 6dj1A-1q3xA:
undetectable
6dj1A-1q3xA:
13.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
None
0.60A 6dj1A-1q9pA:
10.1
6dj1A-1q9pA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
None
1.35A 6dj1A-1sivA:
18.5
6dj1A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.52A 6dj1A-1sivA:
18.5
6dj1A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
None
0.74A 6dj1A-1sivA:
18.5
6dj1A-1sivA:
49.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ugs NITRILE HYDRATASE
ALPHA SUBUNIT


(Pseudonocardia
thermophila)
PF02979
(NHase_alpha)
5 GLY A  76
ASP A  92
GLY A  87
GLY A  86
ILE A  85
None
0.76A 6dj1A-1ugsA:
undetectable
6dj1A-1ugsA:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1usy ATP
PHOSPHORIBOSYLTRANSF
ERASE REGULATORY
SUBUNIT


(Thermotoga
maritima)
PF13393
(tRNA-synt_His)
5 ALA C 251
VAL C 114
ILE C 238
VAL C 109
ILE C 113
None
0.60A 6dj1A-1usyC:
undetectable
6dj1A-1usyC:
14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x7h PUTATIVE KETOACYL
REDUCTASE


(Streptomyces
coelicolor)
PF00106
(adh_short)
5 GLY A 117
ASP A  63
GLY A  13
VAL A  74
ILE A  70
None
NDP  A 301 (-3.7A)
NDP  A 301 (-3.3A)
None
None
0.84A 6dj1A-1x7hA:
undetectable
6dj1A-1x7hA:
17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ab5 MRNA MATURASE

(Saccharomyces
cerevisiae)
PF00961
(LAGLIDADG_1)
5 VAL A 440
GLY A 270
GLY A 407
ILE A 406
ILE A 444
None
0.89A 6dj1A-2ab5A:
undetectable
6dj1A-2ab5A:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ash QUEUINE
TRNA-RIBOSYLTRANSFER
ASE


(Thermotoga
maritima)
PF01702
(TGT)
5 ASP A 142
GLY A  92
GLY A 242
ILE A 214
ILE A 182
None
None
EDO  A 404 ( 4.5A)
EDO  A 404 (-4.0A)
None
0.81A 6dj1A-2ashA:
undetectable
6dj1A-2ashA:
12.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.57A 6dj1A-2fmbA:
14.8
6dj1A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 ASP A  25
GLY A  27
GLY A  54
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.65A 6dj1A-2fmbA:
14.8
6dj1A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  29
VAL A  32
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.90A 6dj1A-2fmbA:
14.8
6dj1A-2fmbA:
29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hhg HYPOTHETICAL PROTEIN
RPA3614


(Rhodopseudomonas
palustris)
PF00581
(Rhodanese)
5 GLY A 127
ALA A 126
ASP A 125
GLY A 119
ILE A  56
None
0.86A 6dj1A-2hhgA:
undetectable
6dj1A-2hhgA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.74A 6dj1A-2isqA:
undetectable
6dj1A-2isqA:
14.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.82A 6dj1A-2rkfA:
20.8
6dj1A-2rkfA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.50A 6dj1A-2rkfA:
20.8
6dj1A-2rkfA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.32A 6dj1A-2rkfA:
20.8
6dj1A-2rkfA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.35A 6dj1A-2rspA:
12.6
6dj1A-2rspA:
30.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w5s PROCESSED GLYCEROL
PHOSPHATE
LIPOTEICHOIC ACID
SYNTHASE


(Staphylococcus
aureus)
PF00884
(Sulfatase)
5 VAL A 469
GLY A 242
GLY A 538
ILE A 539
ILE A 249
None
ACT  A1643 ( 3.8A)
ACT  A1643 ( 4.4A)
None
None
0.75A 6dj1A-2w5sA:
undetectable
6dj1A-2w5sA:
11.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2whx SERINE
PROTEASE/NTPASE/HELI
CASE NS3


(Dengue virus)
PF00949
(Peptidase_S7)
PF07652
(Flavi_DEAD)
5 GLY A 198
ALA A 197
GLY A  82
GLY A 172
ILE A 171
ADP  A1619 (-3.0A)
ADP  A1619 (-4.0A)
None
None
None
0.87A 6dj1A-2whxA:
undetectable
6dj1A-2whxA:
8.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bn6 LACTADHERIN

(Bos taurus)
PF00754
(F5_F8_type_C)
5 GLY A   6
VAL A 138
GLY A  72
ILE A  74
ILE A  62
None
0.70A 6dj1A-3bn6A:
undetectable
6dj1A-3bn6A:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3buj CALO2

(Micromonospora
echinospora)
PF00067
(p450)
5 GLY A 170
ALA A 171
ASP A 175
VAL A  66
GLY A 164
None
0.83A 6dj1A-3bujA:
undetectable
6dj1A-3bujA:
11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cfu UNCHARACTERIZED
LIPOPROTEIN YJHA


(Bacillus
subtilis)
PF11611
(DUF4352)
5 GLY A 131
ALA A 191
ASP A 192
GLY A 158
GLY A 157
None
0.78A 6dj1A-3cfuA:
undetectable
6dj1A-3cfuA:
23.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dbg PUTATIVE CYTOCHROME
P450


(Streptomyces
coelicolor)
PF00067
(p450)
5 GLY A 359
ALA A 360
ASP A 361
PRO A  24
ILE A 356
None
0.84A 6dj1A-3dbgA:
undetectable
6dj1A-3dbgA:
9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.79A 6dj1A-3gveA:
undetectable
6dj1A-3gveA:
13.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
None
0.77A 6dj1A-3i5gA:
undetectable
6dj1A-3i5gA:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3klj NAD(FAD)-DEPENDENT
DEHYDROGENASE,
NIRB-FAMILY
(N-TERMINAL DOMAIN)


(Clostridium
acetobutylicum)
PF07992
(Pyr_redox_2)
5 ALA A 156
GLY A 148
GLY A 149
ILE A 150
ILE A 197
None
0.68A 6dj1A-3kljA:
undetectable
6dj1A-3kljA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kvo HYDROXYSTEROID
DEHYDROGENASE-LIKE
PROTEIN 2


(Homo sapiens)
PF00106
(adh_short)
5 GLY A 128
ASP A  74
GLY A  17
VAL A  85
ILE A  81
None
NAP  A 501 (-3.5A)
NAP  A 501 (-3.3A)
None
None
0.89A 6dj1A-3kvoA:
undetectable
6dj1A-3kvoA:
13.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mmp ELONGATION FACTOR TU
2, ELONGATION FACTOR
TS


(Escherichia
coli)
PF00009
(GTP_EFTU)
PF00889
(EF_TS)
PF03143
(GTP_EFTU_D3)
PF03144
(GTP_EFTU_D2)
5 GLY A  16
ALA A  17
ASP A  21
GLY A 126
ILE A 125
None
0.89A 6dj1A-3mmpA:
undetectable
6dj1A-3mmpA:
9.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
None
1.38A 6dj1A-3mwsA:
20.1
6dj1A-3mwsA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
VAL A  82
None
0.61A 6dj1A-3mwsA:
20.1
6dj1A-3mwsA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  48
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.47A 6dj1A-3mwsA:
20.1
6dj1A-3mwsA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
VAL A  82
None
0.72A 6dj1A-3mwsA:
20.1
6dj1A-3mwsA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.72A 6dj1A-3mwsA:
20.1
6dj1A-3mwsA:
76.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 GLY A 419
ALA A 420
ASP A 421
VAL A 402
ILE A 457
None
0.87A 6dj1A-3opyA:
undetectable
6dj1A-3opyA:
6.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oyt 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE I


(Yersinia pestis)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 333
VAL A  22
GLY A 236
GLY A 235
ILE A  15
None
0.89A 6dj1A-3oytA:
undetectable
6dj1A-3oytA:
11.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p1z PUTATIVE
UNCHARACTERIZED
PROTEIN


(Aeropyrum
pernix)
PF01974
(tRNA_int_endo)
5 GLY A 139
ALA A 140
ASP A 143
GLY A 102
VAL A 149
None
0.74A 6dj1A-3p1zA:
undetectable
6dj1A-3p1zA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ptw MALONYL COA-ACYL
CARRIER PROTEIN
TRANSACYLASE


(Clostridium
perfringens)
PF00698
(Acyl_transf_1)
5 GLY A 153
ALA A 174
GLY A 130
GLY A 129
ILE A 128
None
0.88A 6dj1A-3ptwA:
undetectable
6dj1A-3ptwA:
15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s8m ENOYL-ACP REDUCTASE

(Xanthomonas
oryzae)
PF07055
(Eno-Rase_FAD_bd)
PF12241
(Enoyl_reductase)
PF12242
(Eno-Rase_NADH_b)
5 GLY A 213
ALA A 212
ILE A 206
VAL A 121
ILE A 122
None
0.81A 6dj1A-3s8mA:
undetectable
6dj1A-3s8mA:
12.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.56A 6dj1A-3slzA:
11.1
6dj1A-3slzA:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
PRO A  89
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-4.0A)
0.64A 6dj1A-3slzA:
11.1
6dj1A-3slzA:
23.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.50A 6dj1A-3t3cA:
18.6
6dj1A-3t3cA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
017  A 201 (-4.0A)
None
0.78A 6dj1A-3t3cA:
18.6
6dj1A-3t3cA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-3.3A)
0.39A 6dj1A-3t3cA:
18.6
6dj1A-3t3cA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
0.52A 6dj1A-3t3cA:
18.6
6dj1A-3t3cA:
76.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tqs RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE A


(Coxiella
burnetii)
PF00398
(RrnaAD)
5 GLY A 105
VAL A  25
GLY A  44
VAL A  20
ILE A  24
None
0.63A 6dj1A-3tqsA:
undetectable
6dj1A-3tqsA:
19.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
None
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.95A 6dj1A-3ttpA:
19.6
6dj1A-3ttpA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
None
017  A 201 (-3.0A)
017  A 201 (-3.3A)
1.30A 6dj1A-3ttpA:
19.6
6dj1A-3ttpA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
None
017  A 201 (-3.0A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.59A 6dj1A-3ttpA:
19.6
6dj1A-3ttpA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
None
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.45A 6dj1A-3ttpA:
19.6
6dj1A-3ttpA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 ( 4.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.59A 6dj1A-3u7sA:
19.9
6dj1A-3u7sA:
77.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uhj PROBABLE GLYCEROL
DEHYDROGENASE


(Sinorhizobium
meliloti)
PF00465
(Fe-ADH)
5 GLY A 116
VAL A 172
GLY A 266
ILE A 149
ILE A 135
GOL  A 487 (-3.9A)
None
None
None
None
0.82A 6dj1A-3uhjA:
undetectable
6dj1A-3uhjA:
16.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
None
0.47A 6dj1A-3uhlA:
16.3
6dj1A-3uhlA:
81.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uzu RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE A


(Burkholderia
pseudomallei)
PF00398
(RrnaAD)
5 GLY A 116
VAL A  31
GLY A  50
VAL A  26
ILE A  30
None
0.78A 6dj1A-3uzuA:
undetectable
6dj1A-3uzuA:
13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w9i MULTIDRUG RESISTANCE
PROTEIN MEXB


(Pseudomonas
aeruginosa)
PF00873
(ACR_tran)
5 ALA A 485
ASP A 408
VAL A 411
GLY A 440
VAL A 416
None
0.89A 6dj1A-3w9iA:
undetectable
6dj1A-3w9iA:
5.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fgu LEGUMAIN

(Homo sapiens)
PF01650
(Peptidase_C13)
5 ALA A  49
VAL A  68
GLY A  98
VAL A  31
ILE A  33
None
0.88A 6dj1A-4fguA:
undetectable
6dj1A-4fguA:
9.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fxg MANNAN-BINDING
LECTIN SERINE
PROTEASE 2 B CHAIN


(Homo sapiens)
PF00089
(Trypsin)
5 GLY H 667
GLY H 650
GLY H 651
VAL H 588
ILE H 590
None
0.80A 6dj1A-4fxgH:
undetectable
6dj1A-4fxgH:
16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hyk DNA POLYMERASE IV

(Sulfolobus
acidocaldarius)
PF00817
(IMS)
PF11798
(IMS_HHH)
5 ALA A  96
ASP A  97
ASP A 110
GLY A 122
VAL A   6
None
0.79A 6dj1A-4hykA:
undetectable
6dj1A-4hykA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpn NUCLEOSIDE
N-RIBOHYDROLASE 1


(Physcomitrella
patens)
PF01156
(IU_nuc_hydro)
5 GLY A  27
ASP A  29
GLY A 142
ILE A  51
ILE A  34
None
CA  A 400 ( 4.5A)
CA  A 400 ( 4.4A)
None
None
0.89A 6dj1A-4kpnA:
undetectable
6dj1A-4kpnA:
15.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpo NUCLEOSIDE
N-RIBOHYDROLASE 3


(Zea mays)
PF01156
(IU_nuc_hydro)
5 GLY A  10
ASP A  12
GLY A 124
ILE A  34
ILE A  17
None
CA  A 401 ( 4.8A)
CA  A 401 ( 4.3A)
None
None
0.85A 6dj1A-4kpoA:
undetectable
6dj1A-4kpoA:
13.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.39A 6dj1A-4njvA:
21.0
6dj1A-4njvA:
86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.74A 6dj1A-4njvA:
21.0
6dj1A-4njvA:
86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.3A)
0.59A 6dj1A-4njvA:
21.0
6dj1A-4njvA:
86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.79A 6dj1A-4njvA:
21.0
6dj1A-4njvA:
86.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.55A 6dj1A-4njvA:
21.0
6dj1A-4njvA:
86.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o0e ISOASPARTYL
PEPTIDASE/L-ASPARAGI
NASE


(Homo sapiens)
PF01112
(Asparaginase_2)
5 GLY A 207
ASP A 199
VAL A 228
GLY A 263
GLY A 264
None
0.73A 6dj1A-4o0eA:
undetectable
6dj1A-4o0eA:
13.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ob1 COBALT-CONTAINING
NITRILE HYDRATASE
SUBUNIT ALPHA


(Pseudonocardia
thermophila)
PF02979
(NHase_alpha)
5 GLY A  76
ASP A  92
GLY A  87
GLY A  86
ILE A  85
None
0.77A 6dj1A-4ob1A:
undetectable
6dj1A-4ob1A:
15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ofs PROBABLE LIPOAMIDE
ACYLTRANSFERASE


(Thermoplasma
acidophilum)
PF00198
(2-oxoacid_dh)
5 GLY A 174
VAL A  59
GLY A 157
GLY A 158
ILE A 159
None
0.78A 6dj1A-4ofsA:
undetectable
6dj1A-4ofsA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ose PUTATIVE HYDROLASE

(Rickettsia
typhi)
PF00561
(Abhydrolase_1)
5 ALA A 122
GLY A 110
GLY A 115
ILE A 116
ILE A 230
None
0.88A 6dj1A-4oseA:
undetectable
6dj1A-4oseA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r0v FE-HYDROGENASE

(Chlamydomonas
reinhardtii)
PF02256
(Fe_hyd_SSU)
PF02906
(Fe_hyd_lg_C)
5 GLY A 258
VAL A  91
GLY A 118
VAL A 220
ILE A 222
None
0.86A 6dj1A-4r0vA:
undetectable
6dj1A-4r0vA:
10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rft COAT PROTEIN

(Redspotted
grouper nervous
necrosis virus)
no annotation 5 ALA A  82
ASP A  81
VAL A 199
GLY A 126
ILE A  63
None
0.78A 6dj1A-4rftA:
undetectable
6dj1A-4rftA:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tqk LECTIN 2

(Agrocybe
aegerita)
PF13517
(VCBS)
5 ASP A 345
GLY A 350
ASP A 290
VAL A 343
GLY A 371
None
0.78A 6dj1A-4tqkA:
undetectable
6dj1A-4tqkA:
11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xox 3-OXOACYL-ACP
SYNTHASE


(Vibrio cholerae)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 329
VAL A  22
GLY A 233
GLY A 232
ILE A  15
None
0.88A 6dj1A-4xoxA:
undetectable
6dj1A-4xoxA:
13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 ASP A  32
GLY A  34
ALA A  35
ASP A  36
VAL A  39
GLY A  58
ILE A 100
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.45A 6dj1A-4ydfA:
12.9
6dj1A-4ydfA:
28.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
None
0.65A 6dj1A-5b18A:
18.1
6dj1A-5b18A:
73.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ihe DNA POLYMERASE II
SMALL SUBUNIT


(Pyrococcus
abyssi)
PF00149
(Metallophos)
5 GLY A 500
ALA A 530
GLY A 534
GLY A 535
ILE A 458
None
None
None
None
ACT  A 705 (-3.9A)
0.84A 6dj1A-5iheA:
undetectable
6dj1A-5iheA:
11.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.50A 6dj1A-5t2zA:
20.1
6dj1A-5t2zA:
80.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ve3 BPPRF

(Paraburkholderia
phytofirmans)
no annotation 5 GLY B  88
ALA B  89
ASP B  90
VAL B  59
ILE B  80
None
0.71A 6dj1A-5ve3B:
undetectable
6dj1A-5ve3B:
12.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vm2 ALCOHOL
DEHYDROGENASE


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 237
ALA A 238
ASP A 239
VAL A 199
ILE A 173
None
0.86A 6dj1A-5vm2A:
undetectable
6dj1A-5vm2A:
10.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xmj FUMARATE REDUCTASE
FLAVOPROTEIN SUBUNIT


(Desulfovibrio
gigas)
no annotation 5 ASP A 233
GLY A 234
GLY A  13
GLY A  12
ILE A  11
FAD  A 701 ( 4.3A)
None
FAD  A 701 (-3.5A)
FAD  A 701 (-2.9A)
FAD  A 701 (-4.7A)
0.77A 6dj1A-5xmjA:
undetectable
6dj1A-5xmjA:
25.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
VAL A  99
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
None
0.53A 6dj1A-6fivA:
15.4
6dj1A-6fivA:
30.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.70A 6dj1A-6upjA:
18.0
6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.83A 6dj1A-6upjA:
18.0
6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
0.79A 6dj1A-6upjA:
18.0
6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
0.57A 6dj1A-6upjA:
18.0
6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.83A 6dj1A-6upjA:
18.0
6dj1A-6upjA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ASP A  25
GLY A  27
GLY A  48
ILE A  50
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 (-3.9A)
None
None
0.68A 6dj1A-6upjA:
18.0
6dj1A-6upjA:
47.50